ATDs, which must be obtained by external party researchers for incoming data sets, MUST BE VERIFIED BY A CONTRACT TEAM OF THE RESEARCH BUREAU BEFORE the data is transferred, as the conditions must be carefully checked on the applicable funding conditions. The eighth data protection principle (see list of the Data Protection Act) requires that personal data cannot be transferred outside the European Economic Area (EU Member States as well as Iceland, Norway and Liechtenstein), unless the country or territory where the data is to be transferred provides an adequate level of protection for personal data. One of the exceptions is that you have permission to do so. Therefore, it is important that you have specified in your participant information sheet and consent form that the data can be transmitted outside the UK or EEA. Without MTA, your proprietary materials can be recondeveloped, analyzed or used for purposes that are unacceptable to you. Their materials can even be transferred, sold or sold to third parties. A well-negotiated MTA clearly defines the authorized use of proprietary materials and defines the applicable restrictions. There will also be provisions relating to the distribution of risks when using materials that can be considered experimental with unknown safety and toxicity profiles. Agreement between organizations that regulates the transfer of one or more datasets from owner/supplier to a third party. Existing data subcontractor agreements need to be identified and verified. A subcontractor is someone who processes personal data on behalf of AI. There are examples of agreements that may be necessary for verification: a DBA must be set up by a member of the research office`s contract team before transmitting data. The parties agree that Schedule B may contain confidential business information that it does not share with third parties, unless required by law or in response to a competent regulatory or government authority or in accordance with Clause I.
The parties may make additional annexes to cover the additional deferrals that will be submitted to the Authority if necessary. Appendix B may, in the alternative, be drafted to cover several transfers. The details of the transmission (as well as the personal data collected) are contained in Appendix B, which is an integral part of the clauses. Through the spokesperson: Dr. Olga Tzortzatou, LLD, is a practicing lawyer in the fields of intellectual property and data protection. Since 2007, she has been a lawyer and, since 2008, she has worked as an in-house legal advisor at the Biomedical Research Foundation of the Athens Academy, primarily as an advisor and advisor on intellectual property and data (patents, trials, etc.). It has also developed and negotiated under several national and European projects (7th PCRD, Horizon 2020, IMI) on behalf of the Brfaa consortia and related agreements. She received her doctorate from the Faculty of Law of the National and Cape Verdean University of Athens. In 2015, his book “The protection of the sensitive data in the field of biomedical research” was published on ELSI themes in the field of biobanking.